ImmunoPrecise Antibodies Statistics
Total Valuation
IPA has a market cap or net worth of $91.85 million. The enterprise value is $93.83 million.
Important Dates
The next estimated earnings date is Monday, September 15, 2025, before market open.
| Earnings Date | Sep 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IPA has 46.15 million shares outstanding. The number of shares has increased by 30.23% in one year.
| Current Share Class | 46.15M |
| Shares Outstanding | 46.15M |
| Shares Change (YoY) | +30.23% |
| Shares Change (QoQ) | +39.42% |
| Owned by Insiders (%) | 9.10% |
| Owned by Institutions (%) | 8.68% |
| Float | 41.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.74 |
| Forward PS | 3.25 |
| PB Ratio | 5.37 |
| P/TBV Ratio | 8.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.57.
| Current Ratio | 2.08 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42.24 |
Financial Efficiency
Return on equity (ROE) is -101.96% and return on invested capital (ROIC) is -17.91%.
| Return on Equity (ROE) | -101.96% |
| Return on Assets (ROA) | -14.81% |
| Return on Invested Capital (ROIC) | -17.91% |
| Return on Capital Employed (ROCE) | -34.93% |
| Revenue Per Employee | $173,968 |
| Profits Per Employee | -$214,508 |
| Employee Count | 102 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 5.18 |
Taxes
| Income Tax | -2.92M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +235.02% in the last 52 weeks. The beta is 0.55, so IPA's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +235.02% |
| 50-Day Moving Average | 1.41 |
| 200-Day Moving Average | 0.69 |
| Relative Strength Index (RSI) | 58.42 |
| Average Volume (20 Days) | 1,350,242 |
Short Selling Information
The latest short interest is 725,308, so 1.57% of the outstanding shares have been sold short.
| Short Interest | 725,308 |
| Short Previous Month | 495,801 |
| Short % of Shares Out | 1.57% |
| Short % of Float | 1.73% |
| Short Ratio (days to cover) | 0.35 |
Income Statement
In the last 12 months, IPA had revenue of $17.74 million and -$21.88 million in losses. Loss per share was -$0.66.
| Revenue | 17.74M |
| Gross Profit | 9.80M |
| Operating Income | -8.96M |
| Pretax Income | -20.89M |
| Net Income | -21.88M |
| EBITDA | -6.74M |
| EBIT | -8.96M |
| Loss Per Share | -$0.66 |
Full Income StatementBalance Sheet
The company has $7.72 million in cash and $9.70 million in debt, giving a net cash position of -$1.98 million or -$0.04 per share.
| Cash & Cash Equivalents | 7.72M |
| Total Debt | 9.70M |
| Net Cash | -1.98M |
| Net Cash Per Share | -$0.04 |
| Equity (Book Value) | 17.10M |
| Book Value Per Share | 0.37 |
| Working Capital | 7.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.64 million and capital expenditures -$578,223, giving a free cash flow of -$5.24 million.
| Operating Cash Flow | -4.64M |
| Capital Expenditures | -578,223 |
| Free Cash Flow | -5.24M |
| FCF Per Share | -$0.11 |
Full Cash Flow StatementMargins
Gross margin is 55.25%, with operating and profit margins of -50.47% and -123.30%.
| Gross Margin | 55.25% |
| Operating Margin | -50.47% |
| Pretax Margin | -139.75% |
| Profit Margin | -123.30% |
| EBITDA Margin | -37.98% |
| EBIT Margin | -50.47% |
| FCF Margin | n/a |
Dividends & Yields
IPA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.23% |
| Shareholder Yield | -30.23% |
| Earnings Yield | -23.82% |
| FCF Yield | -5.71% |
Analyst Forecast
The average price target for IPA is $4.00, which is 101.01% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 101.01% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 18.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 23, 2020. It was a reverse split with a ratio of 1:5.
| Last Split Date | Nov 23, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
IPA has an Altman Z-Score of -3.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.37 |
| Piotroski F-Score | 4 |